Fucoidan Japan

06/12/2022

The following SING A LONG is organized by Infant Jesus Church Nedimala to collect funds for much needed renovations of the Church Building and Sunday School Building where children of around 250 familys receive their first hand spiritual education.

The event is also held to coincide with the significant milestone of the Nedimala Infant Jesus Church celebrating it's Silver Jubilee in 2023.

I encourage thoes who are interested in purchasing tickets for the event to please contact the numbers reflected.

We also are seeking sponsorships to make this event a success and appreciate thoes interested in coming forward to please contact me on 0777781090 enabling me to get in touch.

May God's choicest blessings be with you all and your families. Amen 🙏

17/10/2017

ANTICANCER PROPERTIES

A diet high in fucoidan may also help prevent and treat cancer. Memorial Sloan-Kettering Cancer Center says several laboratory studies have shown that fucoidan has medicinal properties that could be helpful in combating some forms of cancer but cautions that human data thus far are lacking. The center cites one study that showed fucoidan appears to inhibit the spread of cancerous cells by preventing the adhesion of tumor cells to the extracellular matrix. In another study, fucoidan induced apoptosis, or programmed cell death, in human T-cell leukemia virus type I, or HTLV-1, that causes adult T-cell leukemia. The polysaccharide paves the way for apoptosis by inactivating NF-kB, a naturally occurring substance that regulates antiapoptotic proteins.

17/10/2017

PLEASE SHARE THE FOLLOWIING WITH THOSE YOU KNOW HAVE BRIAN OR ANY OTHER CANCER.

ALSO TELL THEM TO CONTACT ME ON 94 777 781090 AS I MARKET FUCOIDAN DX WHICH IS MANUFACTURED USING SEA W**D AND HAS NO SIDE EFFECTS AS IT'S A NATURAL PRODUCT ANS HELPS IN THE CURE OF CANCER.

MOREOVER, IT ALSO HELPS IN REDUCING SIDE EFFECTS OF RADIATION & CHEMOTHERAPY.

Readers of this blog of a certain age might remember Chachi Arcola, Fonzie’s younger cousin on the 70s sitcom Happy Days. The actor, Scott Baio, has mostly retired from acting, but recently m…

07/10/2017

https://www.google.lk/url?sa=t&source=web&rct=j&url=https://www.ncbi.nlm.nih.gov/pubmed/27216370&ved=0ahUKEwjampDr893WAhUJEpQKHblfCGMQFggrMAA&usg=AOvVaw0QG0KBZjVo5e3eMivqzF3m

17/09/2017

27/06/2017

Hepatitis B

Female in the 60s
Chief Complaint: No significant symptoms
Past Medical History: Depression

Current Medical History:
She had received treatment for hepatitis B at another hospital for about 20 years. She had been intravenously given 5 ampoules of conservative treatment of liver sick drug (SMC) four days a week, however no improvement had been observed. She visited our clinic in August 2002. After the informed consent procedure, she began taking fucoidan mix as a treatment option without impairing the QOL.

Treatment outcomes:
After taking 1.0g of fucoidan mix per day, her levels of GOT were reduced to 9450, and her GPT levels were reduced to 79 from 36. She had received 5 ampoules of liver asylum agent (SMC) (intravenous injection) at the previous hospital. During the treatment at our hospital, the agent was reduced to 1 ampoule from 3 ampoules, then administration of SMC became no longer necessary 6 months later.

※Data taken over the period of treatment

【Biochemistry tests】
Fucoidan mix intake per day: Approximately 1.0ｇ

May 2002August 2002October 2002March 2003June 2004GOT
(10〜40)10794794550(IU/l)GPT
(5〜40)11579663736(IU/l)

SMC　5A→3A→1A→off（Half a year later）

Hepatitis C

Female in the 60s
Chief Complaint: No significant symptoms
Past Medical History: Angina pectoris

Current Medical History:
She had received treatment for hepatitis C at another hospital. She visited our clinic in March 2003. After the informed consent procedure, she began treatment with fucoidan mix.

Treatment outcomes:
After taking approximately 1g of fucoidan mix per day, her levels of AFP were decreased to 12.0 from 33.4 in approximately 2 months.

※Data taken over the period of treatment

【Tumor markers】

March 2003May 2003November 2004AFP (< 10.0)33.423.612.0(ng/ml)

Intractable duodenal ulcer

Female in the 80s
Chief Complaint: Abdominal pain
Medical History: intractable duodenal ulcer, rheumatoid arthritis and angina pectoris

Current Medical history:
She received helicobacter pylori eradication and PPI therapy, to combat the duodenal ulcer in May 2002 which then improved. Then, in August the same year, it relapsed. Again, she received H. pylori eradication treatment and PPI therapy. However, there were no signs of improvement this time. This was the time when we proposed the administration of fucoidan mix. After providing sufficient information on fucoidan, she and her family members agreed and she began receiving fucoidan mix treatment. Her condition improved dramatically enough to be discharged from hospital. Thereafter, we continued prescribing fucoidan mix and PPI. She visited our hospital complaining of abdominal pain in June 2003. The examination result showed that the duodenal ulcer had relapsed. After interviewing the patient, it was found that she had made her own judgement and discontinued taking fucoidan mix since April 2003. She had continued only the PPI. So, we started the administration of fucoidan mix again.

Treatment outcomes:
When her duodenal ulcer was found to have relapsed, she was provided with fucoidan mix. In one week, the ulcer improved.

※Data taken over the period of treatment

《Endoscope of the duodenal ulcer area》
Fucoidan mix intake per day: Approximately 2.5ｇ

June 2003 Recurrence of Duodenal ulcer

June 2003, one week after the discovery of duodenal ulcer recurrence

Intractable gastric ulcer

Female in the 60s
Chief Complaint: Epigastric pain
Past Medical History: Gastric ulcer

Current Medical History:
She had been administered PPI, but gastric ulcer had continued recurring over several years, which developed into intractable gastric ulcer. In April 2013 she began fucoidan treatment.

Treatment outcomes:
Intractable gastric ulcer was improved in about four months after the initiation of the combination treatment of fucoidan and PPI.
※Data taken over the period of treatment

《Endoscopy of the upper gastrointestinal tract》
Daily dosage of fucoidan mix in April 2013 ~ 1.25g
Daily dosage of fucoidan mix in June 2013 ~ 0.75g

April 2013

August 2013

Fucoidan mix・・・It is composed of mozuku extracted fucoidan, mekabu extracted fucoidan and agaricus mycelium.

Today, active research is conducted on fucoidan and various bioactive functions of fucoidan, such as “anti-cancer action,” “cholesterol-lowering action,” “blood-pressure lowering action” and “anti-virus action,” have been revealed.

27/06/2017

Brain tumor and lung metastasis

Male in the 80s
Chief Complaint: No significant symptoms
Past Medical history: Not significant

Current Medical History:
He was given a brain tumor diagnosis in February 2009. Then lung metastases was observed in February 2010. Without undergoing chemotherapy, he began treatment with only fucoidan.

Treatment Outcomes:
After taking 2.5g of fucoidan mix per day, disappearance of the brain tumor was confirmed in March 2010. In addition, his QOL was also improved.

※Data taken over the period of treatment

《MRI of the head》
Fucoidan mix intake per day: Approximately 2.5ｇ

February 2009

March 2010

Fucoidan mix・・・It is composed of mozuku extracted fucoidan, mekabu extracted fucoidan and agaricus mycelium.

Today, active research is conducted on fucoidan and various bioactive functions of fucoidan, such as “anti-cancer action,” “cholesterol-lowering action,” “blood-pressure lowering action” and “anti-virus action,” have been revealed.

27/06/2017

Cholangiocarcinoma

Male in the 80s
Chief Complaint: Jaundice
Past Medical history: No significant diseases

Current medical history:
He visited a nearby hospital complaining of, primarily, jaundice in July 2013. In a bile duct cancer examination, tumors were found in the hepatic portal section and the bile duct, and obstructive jaundice was developed. A PTCD-tube was inserted on July 16, 2013 and followed by a stent on August 23 in an attempt to reduce pressure in the bile duct and mitigate jaundice. He visited our hospital seeking for palliative care in September 9, 2013. He began fucoidan therapy, without any aggressive treatments including chemotherapy (his family members also declined such treatments), taking his age into consideration.

Treatment Outcomes:
His tumor shrank with only fucoidan therapy. CA-19-9 levels were improved to 434.4 from 1170, and the levels of ALP were improved to 509 from 1179, and the levels of γ-GTP also were improved to 13 from 230. The jaundice disappeared and he had no further pain.

※Data taken over the period of treatment

《CT images of the abdomen》

Fucoidan mix intake per day: Approximately 4.0g

September 2013

June 2014



【Tumor markers】

September 2013June 2014CA19-9(≦ 37.0)1170.0434.4(U/ml)



【Biochemistry tests】

September 2013June 2014ALP(115 ~ 359)1179509(U/l)γ-GTP (< 70)23013(U/l)

Bile duct cancer, liver metastasis and bone metastasis

Male in his 40s
Chief Complaint: No significant symptoms
Past Medical History: Not significant

Current Medical History:
In March 2011, he was diagnosed with stage Ⅳ bile duct cancer, and the tumor had spread to the liver and bones. In April the same year, he began fucoidan therapy in combination with chemotherapy.

Treatment Outcomes:
He began fucoidan therapy in April 2011. By July the same year, the size of tumor was reduced to 2.0cm × 2.0cm from 2.9cm × 2.3cm. There were no side effects from chemotherapy, and the QOL was also improved.

※Data taken over the period of treatment

《CT images of abdomen》

Fucoidan mix intake per day: Approximately 5.0ｇ

Tumor size：2.9cm×2.3cm
March 2011

Tumor size：2.0cm×2.0cm
July 2011

Fucoidan mix・・・It is composed of mozuku extracted fucoidan, mekabu extracted fucoidan and agaricus mycelium.

Today, active research is conducted on fucoidan and various bioactive functions of fucoidan, such as “anti-cancer action,” “cholesterol-lowering action,” “blood-pressure lowering action” and “anti-virus action,” have been revealed.

27/06/2017

Colon cancer and liver metastasis

Female in the 40s
Chief Complaint: No significant symptoms
Medical History: Not significant

Current Medical History:
She was diagnosed with colon cancer and liver metastasis in February 2010. She was advised to receive chemotherapy which she refused. She began fucoidan therapy in April the same year, and also began chemotherapy in September due to the development of ascites.

Treatment Outcomes:
Her CEA levels were decreased from 1535.7 to 33.32 , and her CA19-9 levels were decreased from 1143 to 32.04. No severe side effects from chemotherapy were observed.

※Data taken over the period of treatment

【Tumor markers】
Fucoidan mix intake per day: Approximately 10.0ｇ

April 2010August 2010December 2010April 2011CEA
(< 5.0)1535.71474.097.2533.32(ng/ml)CA19.9
(< 35.0)1143179619432.04(U/ml)



【Tumor sizes】

January 2011May 2011S6,S7(Right)14.3×12.412.6×10.9(cm)S3(Left)12.7×6.410.8×6.1(cm)

Fucoidan mix・・・It is composed of mozuku extracted fucoidan, mekabu extracted fucoidan and agaricus mycelium.

Today, active research is conducted on fucoidan and various bioactive functions of fucoidan, such as “anti-cancer action,” “cholesterol-lowering action,” “blood-pressure lowering action” and “anti-virus action,” have been revealed.

27/06/2017

Carcinoma peritonitis developed after the total gastrectomy, re**al stenosis induced by peritoneal dissemination (which had spread to the pouch of Douglas) and Sigmoid colon stenosis

Male in the 50s
Chief Complaint: Problems with defecation and pasting flatus, abdominal distension
Past Medical History: Gastric cancer, total gastrectomy, lymph node dissection, splenectomy, cholecystectomy

Current Medical History:
In January 2004, intestinal obstruction occurred induced by the Schnitzler metastasis, and he was administered Total Parenteral Nutrition(TPN)(a method of getting nutrition intravenously) at another hospital. He received chemotherapy with TS-1 because his condition at the time was to the extent that his doctor needed to consider performing a colostomy, which he had to discontinue because of the side effects from the liver dysfunction, and used Taxotere instead. He visited our clinic in February 2004 to continue medical treatment. I determined that Taxotere was not working on him. After he was provided with sufficient information on fucoidan, he resumed chemotherapy using TS-1, accompanied by fucoidan mix.

Treatment Outcomes:
After he was administered 4g of fucoidan mix a day, PHA levels increased to the reference value. His liver started functioning and he was able to eat. An idea of performing a colostomy, which had been considered earlier, was no longer necessary. His condition improved, which was classified as close to CR (complete response).

※Data taken over the period of treatment

《X-ray images taken during a barium enema》

Fucoidan mix intake per day: Approximately 4.0g

March 2004

May 2004

October 2004



【Tumour markers】

February 2004July 2004November 2004May 2005CA19-9（＜37.0）76383532(U/ml)CA125（＜35.0）4326.322.721.6(U/ml)



【Immune function tests】

July 2004November 2004April2005IL-2R(220 ~ 530)543349491(U/ml)PHA(26,000~53,000)18,14228,49138,539(CPM)Con-A(20,000~48,000)23,79530,60342,783(CPM)

Gastric cancer and lymph node metastasis

Male in the 80s
Chief Complaint: Epigastralgia
Past Medical History: Not significant

Current medical history:
He visited a nearby hospital complaining of stomachache in May 2004. He was diagnosed with gastric cancer which had spread to the hepatic portal section, which were no longer inoperable. The doctor predicted that his prognosis is 3 months. He visited our clinic seeking a second opinion and information on fucoidan. After a detailed examination, he was diagnosed with gastric cancer accompanied by duodenal invasion and pyloric stenosis. In addition, hilar lymph node metastasis accompanied by an extension of intrahepatic bile duct was also observed. In order to perform treatment without degrading the QOL, he was administered low dose chemotherapy of UFT, which was fewer than half of the regular dosage, at the same time he began taking fucoidan mix.

Treatment Outcomes:
After starting the administration of UFT and fucoidan mix, his tumor markers reduced.
In addition, no degrading of his QOL,immune system and no symptoms such as jaundice were observed.

※Data take over the period of treatment

《X-ray images and CT images of the abdomen》

Fucoidan mix intake per day: Approximately 8.0g

June 2004

June 2004

【Tumor markers and Immune index】

August 20042October 2004December 2004January 2005CEA(< 5.0)11.98.97.9(ng/ml)CA19-9(< 37.0)310344304274(U/ml)CA125(< 35.0)19.517.7(U/ml)IL-2R(220~530)821613561(U/ml)

Cardia cancer

Male in the 80s
Chief Complaint: Hematemesis
Past Medical History: Cerebral infarction and angina pectoris

Current medical history:
He visited our clinic complaining of, primarily, Hematemesis in July 2002. A detailed examination showed that he had gastric cardiac carcinoma. He and his family members refused to have surgical procedures, given his old age of 80. He also developed diseases such as cerebral infarction and angina pectoris. For the reasons, he was administered only fucoidan mix, without using any chemo drug, after the informed consent process.

Treatment Outcomes:
After taking 3.0g of fucoidan mix per day for two months, the tumor almost disappeared.
※Data taken over the period of treatment

《Endoscopy images of upper gastro intestine》
Fucoidan mix intake per day: Approximately 3.0ｇ

July 2002

September 2002

Data provided by Matsuzaki Memorial Hospital

Fucoidan mix・・・It is composed of mozuku extracted fucoidan, mekabu extracted fucoidan and agaricus mycelium.

Today, active research is conducted on fucoidan and various bioactive functions of fucoidan, such as “anti-cancer action,” “cholesterol-lowering action,” “blood-pressure lowering action” and “anti-virus action,” have been revealed.

27/06/2017

Left o***y cancer, Cancerous peritonitis, Cancerous ascites

Female in the 30s
Chief Complaint: Abdominal fullness
Past Medical History: Not significant

Current Medical History:
She visited a university hospital due to abdominal fullness in October 2003, and was diagnosed with left ovarian cancer, carcinomatous peritonitis and carcinomatous ascites. She was advised to have a surgery, chemotherapy and radiation therapy, but she refused any of them. She visited our clinic in November to seek a second opinion as well as information on fucoidan. Similarly, we advised her to have a surgery, chemotherapy and radiation therapy, but she refused. After she was provided with sufficient information on fucoidan mix, she began fucoidan mix only therapy.

Treatment Outcome:
Her tumor markers were lowered, and CT images showed that her tumor had reduced from 11cm to 6cm.

※Data taken over the period of treatment

《CT images of the pelvis》

Fucoidan mix intake per day: Approximately 8.0g
※ At the time of data

November 2003

January 2004

August 2005



【Tumor markers】

November 2003November 2004August 2005CA19-9 (< 37.0)10762.457002573(U/ml)CA125 (< 35.0)1076.2820220.4(U/ml)

Data provided by Matsuzaki Memorial Hospital

Fucoidan mix・・・It is composed of mozuku extracted fucoidan, mekabu extracted fucoidan and agaricus mycelium.

Today, active research is conducted on fucoidan and various bioactive functions of fucoidan, such as “anti-cancer action,” “cholesterol-lowering action,” “blood-pressure lowering action” and “anti-virus action,” have been revealed.